ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Congress: Gore, Democrats Rally For Anti-Tobacco Legislation

February 20, 1998

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

Community Oncology Alliance Attack On Republican Leadership Prompts Others To Declare: We Aren’t COA.

September 29, 2006

Another Potti Paper Retracted

September 16, 2011

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978